maturity-onset diabetes of the young type 2

Summary

maturity-onset diabetes of the young type 2 is a class of disease^[1]. It draws 11 Wikipedia views per month (class_of_disease category, ranking #621 of 1,968).^[2]

Key Facts

• maturity-onset diabetes of the young type 2's instance of is recorded as class of disease^[3].
• maturity-onset diabetes of the young type 2's subclass of is recorded as maturity-onset diabetes of the young^[4].
• maturity-onset diabetes of the young type 2's OMIM ID is recorded as 125851^[5].
• maturity-onset diabetes of the young type 2's Disease Ontology ID is recorded as DOID:0111100^[6].
• maturity-onset diabetes of the young type 2's NCI Thesaurus ID is recorded as C129741^[7].
• maturity-onset diabetes of the young type 2's health specialty is recorded as endocrinology^[8].
• maturity-onset diabetes of the young type 2's drug or therapy used for treatment is recorded as miglitol^[9].
• maturity-onset diabetes of the young type 2's drug or therapy used for treatment is recorded as glipizide^[10].
• maturity-onset diabetes of the young type 2's drug or therapy used for treatment is recorded as insulin glargine^[11].
• maturity-onset diabetes of the young type 2's drug or therapy used for treatment is recorded as pramlintide^[12].
• maturity-onset diabetes of the young type 2's drug or therapy used for treatment is recorded as exenatide^[13].
• maturity-onset diabetes of the young type 2's drug or therapy used for treatment is recorded as Insulin Lispro^[14].
• maturity-onset diabetes of the young type 2's drug or therapy used for treatment is recorded as (RS)-troglitazone^[15].
• maturity-onset diabetes of the young type 2's drug or therapy used for treatment is recorded as (RS)-rosiglitazone^[16].
• maturity-onset diabetes of the young type 2's drug or therapy used for treatment is recorded as tolazamide^[17].
• maturity-onset diabetes of the young type 2's drug or therapy used for treatment is recorded as nateglinide^[18].
• maturity-onset diabetes of the young type 2's drug or therapy used for treatment is recorded as chlorpropamide^[19].
• maturity-onset diabetes of the young type 2's drug or therapy used for treatment is recorded as sitagliptin^[20].
• maturity-onset diabetes of the young type 2's drug or therapy used for treatment is recorded as acarbose^[21].
• maturity-onset diabetes of the young type 2's drug or therapy used for treatment is recorded as (RS)-pioglitazone^[22].
• maturity-onset diabetes of the young type 2's drug or therapy used for treatment is recorded as glyburide^[23].
• maturity-onset diabetes of the young type 2's drug or therapy used for treatment is recorded as glimepiride^[24].
• maturity-onset diabetes of the young type 2's drug or therapy used for treatment is recorded as repaglinide^[25].
• maturity-onset diabetes of the young type 2's drug or therapy used for treatment is recorded as acetohexamide^[26].
• maturity-onset diabetes of the young type 2's drug or therapy used for treatment is recorded as tolbutamide^[27].

Why It Matters

maturity-onset diabetes of the young type 2 draws 11 Wikipedia views per month (class_of_disease category, ranking #621 of 1,968).^[2]